Product Center
Products Center
I. The company has been approved to establish a national level postdoctoral research workstation
II. The company's drug surveillance work was commended by the National Center
2025-08-01
I. TOP100 Chinese Traditional Medicine Enterprises in 2023
II. The company was selected as the eighth batch of national key leading enterprises in agricultural industrialization.
III. Jiuhua Huayuan Pharmaceutical won the title of national specialized special new "little giant" enterprise
Ⅳ. The company has been awarded as a law-abiding and trustworthy enterprise in the pharmaceutical industry for the year 2023-2024
Ⅴ. The company has been rated as one of the top 50 pharmaceutical industry growth rate enterprises for 2023-2024
Ⅵ. The company has been awarded the title of Excellent Demonstration Base for Authentic Traditional Chinese Medicine Planting (Breeding) in 2023-2024
Ⅶ. Chairman Guan Yueqin was named one of the "Top Ten Emerging Figures in China's Pharmaceutical Industry"
Ⅷ. Bairui Granules has been awarded the title of "Chinese Family Regular Medicine Listed Brand"
2024-09-30
I. Won the "2022 Top 100 traditional Chinese patent medicines and simple preparations enterprises"
II. Entering the TOP 100 Chinese Traditional Chinese Medicine Enterprises in 2022
III. Awarded the honorary title of "Top 50 Growing Enterprises in the Pharmaceutical Industry"
IV. Continuously awarded the title of "Integrity and Law abiding Enterprise in the Pharmaceutical Industry" nationwide
In August, the company was renamed Jiuhua Huayuan Pharmaceutical Co., Ltd
2024-09-30
Ⅰ. Won the title of "Top Ten Enterprises" in Langya District, Chuzhou City in 2021
Ⅱ. Jiuhua&huayuan has been selected as the top strength and high-quality development achievement enterprise of Chinese Medicine
Ⅲ. Ranked among the top 20 leading enterprises in agricultural industrialization in 2022
Ⅳ. Shortlisted as the top 100 Chinese traditional medicine enterprises in 2021
Ⅴ. Baimeixing ® Bairui granule was listed in the "Chinese medicine brand list"
2022-06-08
Ⅰ. The company won the title of "2020 Law-abiding and Integrity Enterprise in China's Pharmaceutical Industry"
Ⅱ. The company has won the list of "2020 Chinese National Pharmaceutical Excellent Brand Enterprises"
Ⅲ. The planting base of Pleurotus is identified as the "Top Ten Anhui Medicines" Industrial Demonstration Base
Ⅳ. The company entered the top 100 Chinese traditional medicine enterprises in 2020
Ⅴ.Bairui Granules and Yuye Jinhua Qingre Tablets appeared at the National "Thirteenth Five-Year" Science and Technology Innovation Achievement Exhibition
Ⅵ. Baimeixing® Bairui Granules entered the "2021 China Pharmaceutical Brand List"
2021-09-14
Ⅰ. The company was selected as the construction unit of the "Top Ten Anhui Medicines" industrial demonstration bases.
Ⅱ. The company was rated as "Provincial Key Leading Enterprise of Agricultural Industrialization".
Ⅲ. Ranked in the TOP100 list of Chinese traditional Chinese medicine enterprises in 2019!
2021-09-14
Ⅰ. The company was rated as "2018 Chuzhou Environmental Protection and Integrity Enterprise".
Ⅱ. Bairui Granules entered the new edition of "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2019 Edition)".
Ⅲ. Zhenyuan Tablet has entered the new version of the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2019 Edition)".
2021-09-14
Ⅰ. The company was recognized as a "high-tech enterprise" for the second time.
Ⅱ. The company was approved to set up "Anhui Postdoctoral Research Station".
Ⅲ. The company was rated as "the city's top ten industrial enterprises in 2017".
Ⅳ. Bairui Granules entered the new edition of "National Essential Medicines List (2018 Edition)".
2021-09-14
Bairui Granules entered the top ten Chinese patent medicines for heat-clearing and detoxification.
2021-09-14
Bairui granules (tablets) are listed in the Infectious Diseases of the Clinical Application Guidelines for Chinese Patent Medicines.
2021-09-14
